Viral Antigens Market
Viral Antigens Market Analysis By Component (Influenza, Ebola, Zika, & Others), By Detection Technique (ELISA, Immunoassay, Immunoperoxidase Staining, & Others), By End User (Hospitals, Laboratories, Diagnostic Centers, Blood Banks, Research Institutes) - Global Insights 2022 to 2032.
Analysis of Viral Antigens market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Viral Antigens Market Outlook (2022-2032)
The global viral antigens market is estimated at US$ 175.9 billion in 2022 and is forecasted to expand at a high-value CAGR of 8.2% to reach a market size of US$ 388.1 billion by the end of 2032.
Viral antigens are gaining attention owing to advancements in microbiology as well as vaccine development, in which, North America is the most favorable market for manufacturers of viral antigens.
Report Attributes |
Details |
|---|---|
|
Viral Antigens Market Size (2021A) |
US$ 159.4 Billion |
|
Estimated Market Value (2022E) |
US$ 175.9 Billion |
|
Forecasted Market Value (2032F) |
US$ 388.1 Billion |
|
Global Market Growth Rate (2022-2032) |
8.2% CAGR |
|
North America Market Share (2021) |
~ 49% |
|
Europe Market Growth Rate (2022-2032) |
~ 8.1% CAGR |
|
United States Market Growth Rate (2022-2032) |
~ 7.9% CAGR |
|
Market Share of Top 5 Companies |
~ 17.4% |
|
Key Companies Profiled |
|
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Sales Analysis of Viral Antigens (2017-2021) Vs. Market Forecasts (2022-2032)
The occurrence of viral diseases as well as the requirement for faster immunity boosting is fueling the need for the administration of viral antigens in the host body. Numerous outbreaks of infectious diseases caused by viruses, such as hepatitis, AIDS, influenza, and the recent COVID-19 virus, have created urgency in vaccine research and development. Additionally, investments in vaccine development by government authorities and key market players are also supporting the introduction and rising awareness of viral antigens.
These factors have amplified the sales of viral antigens during the historical period (2017-2021) at a CAGR of 7.7%.
Most of the newly established techniques, such as the electron microscopy workflow, are promising for advancements in viral research. For example, with the development of image systems, it is possible to capture an image in real time and produce immunoassay results that are efficient and reproducible.
In addition, electron microscopy is emerging as a potential technique to recognize viral antigens and determine their structural organization and localization within viruses and vaccines. Hence, rising awareness of electron microscopy among specialists in vaccine research and related stakeholders are guiding their focus to this category.
Fact.MR predicts that the global viral antigens market will be valued at US$ 388.1 billion by 2032, expanding at a CAGR of 8.2% over the decade.
- Short Term (2022-2025): The outbreak of viral diseases and demand for faster immunity boosting will generate a higher need for viral antigens in the short-term period.
- Medium Term (2025-2028): Investments in vaccine developments and rising awareness about viral antigens will see huge acceptance in the market during the period 2025 to 2028.
- Long Term (2028-2032): Technological advancements in molecular biology will drive market growth for a longer period.
Over the 2017-2021 historical period, the global viral antigens market progressed at a CAGR of 7.7%, and according to Fact.MR, a market research and competitive intelligence provider, the industry is expected to surge ahead at 8.2% CAGR through 2032.
Market share analysis of viral antigens based on detection technique and region. Under the detection technique segment, ELISA dominates with 31.6% market share in 2022.
Why is Demand for Viral Antigens So High?
“Advancements in Image Analysis Software & Informatics Platforms”
Technological developments such as the electron microscopy workflow are assisting in the speedy development of viral research activities. The possibility of capturing pictures and videos of viral antigen immunogenicity analysis in HD mode due to technological and scientific advancements is a key factor contributing to market growth.
Additionally, modern research has ensured the development of sophisticated automated tools that can capture superior quality HD images in various phases. Apart from this, differential cell analysis can be done with the help of these devices, which results in reproducible images in red and green fluorescent contrasting outlines.
As such, these are suitable tools that can be used for varied parallel applications in the viral antigens market.
“Intensifying Outbreaks of Virus-Borne Diseases”
In the previous decades, the entire world was facing the outbreak of several infectious viruses, which became a severe threat to global health and the economy. This scenario is not over yet, for which the COVID-19 pandemic is a big example. It is anticipated that the world will face the same situation in the future owing to changing viral protein structures and mutations.
Various factors such as globalization, urbanization, aging, international commerce, and climate change have supported the emergence, transmission, and spread of pathogens. As viral antigens play a vital role in boosting immunity, the outbreak of various infectious diseases will spur the global demand for viral antigens.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
What Do Viral Antigen Manufacturers Need to Watch Out For?
“Less Immunogenicity than Inactivated Whole-virus Vaccines Lowering Market Value”
Every product or technology comes with some advantages as well as drawbacks, and viral antigens have their own drawbacks that limit their demand growth. As viral antigens are the proteins present on the surface of a virus, the evolving structure of a protein by the virus may require further production of new viral antigens. This repetitive procedure is costly as well as very time-consuming.
Also, inactivated whole-virus vaccines are undergoing treatments called attenuation that help improve the immunogenicity of the host body. Therefore, the advantage of whole-virus vaccines over viral antigens may limit the acceptance of viral antigens across regions over the years to come.
Country-wise Insights
Will Rising R&D Investments in the U.S. Drive High Demand for Viral Antigens?
The viral antigens market in the United States is expected to expand at a CAGR of 7.9% from 2022 to 2032.
In North America, the U.S. is ruling the viral antigens market in 2022 due to high investments in R&D and the fast-growing technological sector. Apart from this, the presence of several key manufacturers of viral antigens is a supporting factor for the market growth in the United States. Rising cases of infectious diseases in the country are generating a huge need for viral antigens.
Why is the East Asia Market Expected to Be Highly Opportunistic?
East Asia accounted for 10% share of the global viral antigens market at the end of 2021.
The growing population and high chances of spreading infectious diseases in East Asia and South Asia and the ASEAN regions are anticipated to make these opportunistic regions for the market players.
Furthermore, developing healthcare facilities as well as an increase in government initiatives will support viral antigens market growth in Japan. Also, rising investments in technology will drive market growth across the Asia Pacific region.
Category-wise Insights
Which Detection Technique is Most Widely Used for Viral Antigens?
Enzyme-linked immunosorbent assay (ELISA) is the most popular and widely used tool for the diagnosis and detection of virus infection. This tool is gaining popularity as being specific, safe, and rapid owing to its capability of producing recombinant viral proteins.
Hence, the acceptance of ELISA for the recognition of viral antigens is anticipated to lead to it holding 31.6% share of the global market share and increase at a CAGR of 8.5% during the forecast period.
Will Hospitals Continue to Rule the Viral Antigens Business Landscape?
In terms of end user, viral antigens are segmented into blood banks, clinics, laboratories, diagnostic centers, and research institutes.
Hospitals are the key contributors to the sales of viral antigens and hold a majority of the share in the global market. The same trend is expected to be witnessed during the forecast period as well. The hospitals segment is projected to account for 28.8% share of the market by the end of 2032.
However, blood banks are the fastest-growing end-user segment in the global market. This segment is anticipated to grow at a CAGR of 11% during the assessment period.
Competitive Landscape
Prominent viral antigen manufacturers are Microbix Biosystems Inc., Bio Rad Laboratories, Creative Diagnostics, Aalto Bio Reagents, ProSpec-Tany TechnoGene Ltd., The native antigen company, Meridian bioscience, Inbios, Rekom biotech, and Sekbio.
Technological improvements in the biopharmaceutical industry are providing substantial growth prospects for viral antigen suppliers. Additionally, manufacturers are focusing on new product launches and product development. Hence, the rise in new product launches and developments, including the introduction of numerous novel recombinant antigens for the growth of antibody tests for COVID-19, will hasten the development of the market.
Apart from organic tactics, key market players are also adopting inorganic growth strategies for business expansion and the generation of a high-revenue share in the market.
- In May 2020, the U.S. FDA issued the EUA to Quidel Corporation for its Sofia 2 SARS Antigen FIA. It is a new category of test that can quickly detect protein particles on or within the coronavirus. The test is conducted by taking samples from the nasal cavity of patients.
- In May 2020, Bio-Rad Laboratories, a U.S.-based developer of high-quality products for the clinical diagnostics market, bagged the EUA approval for its SARS-CoV-2 Total Ab test from the U.S. FDA. It is a blood-based test for identifying the antibodies created by the human body in response to COVID-19.
Fact.MR has provided detailed information about the price points of key manufacturers of viral antigens positioned across regions, sales growth, production capacity, and speculative technological expansion, in the recently published report.
Segmentation of Viral Antigens Industry Research
-
By Component :
- Influenza
- Coronavirus
- Zika
- Ebola
- Dengue
- Herpes Simplex Virus (HSV)
- Rotavirus
- Epstein-Barr
- Hepatitis A-E
- Parainfluenza
- Measles
- Adenovirus
- Mumps/Parotitis
- Varicella Zoster Virus (VZV)
- Others
-
By Detection Technique :
- ELISA
- Immunoassay
- Hemagglutination
- Radioimmunoassay (RIA)
- Immunoperoxidase Staining
- Immunofluorescence
- Electron Microscopy
- Others
-
By End User :
- Hospitals
- Clinics
- Laboratories
- Diagnostic Centers
- Blood Banks
- Research Institutes
-
By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia & ASEAN
- Oceania
- MEA
Table of Content
1. Viral Antigens Market - Executive Summary 2. Market Overview 2.1. Market Definition and Introduction 2.2. Market Taxonomy/ Research Scope 3. Market Background and Foundation Data 3.1. Global Viral Antigens Market Outlook 3.2. Impact of Increasing per Capita Healthcare Spending on Viral Antigen Market 3.3. Diagnosis Seeking Rate 3.4. Comparison of Different Viral Antigens and Scope of improvement 3.5. Viral Antigens Production Analysis 3.5.1. By Region 3.5.2. By Key companies 3.6. Growth & Development Pattern in Viral Antigens Market 3.7. Viral Antigens Market Opportunity Assessment 3.7.1. Total Available Market ((US$ Billion) 3.7.2. Serviceable Addressable Market ((US$ Billion) 3.7.3. Serviceable Obtainable Market ((US$ Billion) 3.8. Market White Space Assessment 3.9. Market Dynamics 3.9.1. Market Growth Drivers 3.9.2. Market Restraints 3.9.3. Market Opportunity 3.9.4. Market Trends 3.10. Forecast and Macro-economic Factors – Relevance and Impact 3.11. PESTLE Analysis 3.12. Porter’s Five Force Analysis 3.13. Investment Feasibility Analysis 3.14. Key Success Factors 4. Global Viral Antigens Market Value ((US$ Billion) Analysis and Forecast 4.1. Historical Market Value ((US$ Billion) Analysis, 2017-2021 4.2. Current and Future Market Value ((US$ Billion) Projections, 2022-2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Viral Antigens Market Analysis and Forecast, By Component 5.1. Introduction / Key Findings 5.2. Historical Market Size ((US$ Billion) Analysis By Component, 2017-2021 5.3. Current and Future Market Size ((US$ Billion) Analysis Forecast By Component, 2022-2032 5.3.1. Influenza Viral Antigens 5.3.2. Coronavirus Antigens 5.3.3. Zika Virus Antigens 5.3.4. Ebola Virus Antigens 5.3.5. Dengue Virus Antigens 5.3.6. Herpes Simplex Virus (HSV) Viral Antigens 5.3.7. Rotavirus Viral Antigens 5.3.8. Epstein-Barr Virus Antigens 5.3.9. Hepatitis A-E Virus Antigens 5.3.10. Parainfluenza Virus Antigens 5.3.11. Measles Virus Antigens 5.3.12. Adenovirus Viral Antigens 5.3.13. Mumps/Parotitis Virus Antigens 5.3.14. Varicella Zoster Virus (VZV) Antigens 5.3.15. Others 5.4. Market Attractiveness Analysis By Component 6. Global Viral Antigens Market Analysis and Forecast, By Detection Technique 6.1. Introduction / Key Findings 6.2. Historical Market Size ((US$ Billion) By Detection Technique, 2017-2021 6.3. Current and Future Market Size ((US$ Billion) Forecast By Detection Technique, 2022-2032 6.3.1. ELISA 6.3.2. Immunoassay 6.3.3. Hemagglutination 6.3.4. Radioimmunoassay (RIA) 6.3.5. Immunoperoxidase Staining 6.3.6. Immunofluorescence 6.3.7. Electron Microscopy 6.3.8. Others 6.4. Market Attractiveness Analysis By Detection Technique 7. Global Viral Antigens Market Analysis and Forecast, By End-user 7.1. Introduction / Key Findings 7.2. Historical Market Size ((US$ Billion) By End-user, 2017-2021 7.3. Current and Future Market Size ((US$ Billion) Forecast By End-user, 2022-2032 7.3.1. Hospitals 7.3.2. Clinics 7.3.3. Laboratories 7.3.4. Diagnostic Centers 7.3.5. Blood Banks 7.3.6. Research Institutes 7.4. Market Attractiveness Analysis By End-user 8. Global Viral Antigens Market Analysis and Forecast, By Region 8.1. Introduction 8.2. Historical Market Size ((US$ Billion) By Region, 2017-2021 8.3. Current Market Size ((US$ Billion) Analysis Forecast By Region, 2022-2032 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. East Asia 8.3.5. South Asia & ASEAN 8.3.6. Oceania 8.3.7. Middle East & Africa 8.4. Market Attractiveness Analysis By Region 9. North America Viral Antigens Market Analysis and Forecast 9.1. Introduction / Key Findings 9.2. Historical Market Size ((US$ Billion) Trend Analysis By Market Taxonomy, 2017-2021 9.3. Market Size ((US$ Billion) Forecast By Market Taxonomy, 2022 - 2032 9.3.1. By Country 9.3.1.1. U.S. 9.3.1.2. Canada 9.3.2. By Component 9.3.3. By Detection Technique 9.3.4. By End-user 9.4. Market Attractiveness Analysis 9.4.1. By Country 9.4.2. By Component 9.4.3. By Detection Technique 9.4.4. By End-user 10. Latin America Viral Antigens Market Analysis and Forecast 10.1. Introduction / Key Findings 10.2. Historical Market Size ((US$ Billion) Trend Analysis By Market Taxonomy, 2017-2021 10.3. Market Size ((US$ Billion) Forecast By Market Taxonomy, 2022 - 2032 10.3.1. By Country 10.3.1.1. Brazil 10.3.1.2. Mexico 10.3.1.3. Argentina 10.3.1.4. Rest of Latin America 10.3.2. By Component 10.3.3. By Detection Technique 10.3.4. By End-user 10.4. Market Attractiveness Analysis 10.4.1. By Country 10.4.2. By Component 10.4.3. By Detection Technique 10.4.4. By End-user 11. Europe Viral Antigens Market Analysis and Forecast 11.1. Introduction / Key Findings 11.2. Historical Market Size ((US$ Billion) Trend Analysis By Market Taxonomy, 2017-2021 11.3. Market Size ((US$ Billion) Forecast By Market Taxonomy, 2022 - 2032 11.3.1. By Country 11.3.1.1. Germany 11.3.1.2. France 11.3.1.3. Italy 11.3.1.4. Spain 11.3.1.5. U.K. 11.3.1.6. BENELUX 11.3.1.7. Russia 11.3.1.8. Rest of Europe 11.3.2. By Component 11.3.3. By Detection Technique 11.3.4. By End-user 11.4. Market Attractiveness Analysis 11.4.1. By Country 11.4.2. By Component 11.4.3. By Detection Technique 11.4.4. By End-user 12. East Asia Viral Antigens Market Analysis and Forecast 12.1. Introduction / Key Findings 12.2. Historical Market Size ((US$ Billion) Trend Analysis By Market Taxonomy, 2017-2021 12.3. Market Size ((US$ Billion) Forecast By Market Taxonomy, 2022 - 2032 12.3.1. By Country 12.3.1.1. China 12.3.1.2. Japan 12.3.1.3. South Korea 12.3.2. By Component 12.3.3. By Detection Technique 12.3.4. By End-user 12.4. Market Attractiveness Analysis 12.4.1. By Country 12.4.2. By Component 12.4.3. By Detection Technique 12.4.4. By End-user 13. South Asia & Oceania Viral Antigens Market Analysis and Forecast 13.1. Introduction / Key Findings 13.2. Historical Market Size ((US$ Billion) Trend Analysis By Market Taxonomy, 2017-2021 13.3. Market Size ((US$ Billion) Forecast By Market Taxonomy, 2022 - 2032 13.3.1. By Country 13.3.1.1. India 13.3.1.2. Thailand 13.3.1.3. Indonesia 13.3.1.4. Malaysia 13.3.1.5. Australia & New Zealand 13.3.1.6. Rest of South Asia & Oceania 13.3.2. By Component 13.3.3. By Detection Technique 13.3.4. By End-user 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Component 13.4.3. By Detection Technique 13.4.4. By End-user 14. Middle East & Africa Viral Antigens Market Analysis and Forecast 14.1. Introduction / Key Findings 14.2. Historical Market Size ((US$ Billion) Trend Analysis By Market Taxonomy, 2017-2021 14.3. Market Size ((US$ Billion) Forecast By Market Taxonomy, 2022 - 2032 14.3.1. By Country 14.3.1.1. GCC Countries 14.3.1.2. South Africa 14.3.1.3. Northern Africa 14.3.1.4. Turkey 14.3.1.5. Rest of Middle East & Africa 14.3.2. By Component 14.3.3. By Detection Technique 14.3.4. By End-user 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Component 14.4.3. By Detection Technique 14.4.4. By End-user 15. Country-level Viral Antigens Market Analysis and Forecast 15.1. Introduction / Key Findings 15.1.1. Market Value Proportion Analysis, By Key Countries 15.1.2. Global Vs. Country Growth Comparison 15.2. US Viral Antigens Market Analysis 15.2.1. Value Proportion Analysis by Market Taxonomy 15.2.2. Value ((US$ Billion) Analysis and Forecast by Market Taxonomy, 2017-2032 15.2.2.1. By Component 15.2.2.2. By Detection Technique 15.2.2.3. By End-user 15.3. Canada Viral Antigens Market Analysis 15.3.1. Value Proportion Analysis by Market Taxonomy 15.3.2. Value ((US$ Billion) Analysis and Forecast by Market Taxonomy, 2017-2032 15.3.2.1. By Component 15.3.2.2. By Detection Technique 15.3.2.3. By End-user 15.4. Brazil Viral Antigens Market Analysis 15.4.1. Value Proportion Analysis by Market Taxonomy 15.4.2. Value ((US$ Billion) Analysis and Forecast by Market Taxonomy, 2017-2032 15.4.2.1. By Component 15.4.2.2. By Detection Technique 15.4.2.3. By End-user 15.5. Mexico Viral Antigens Market Analysis 15.5.1. Value Proportion Analysis by Market Taxonomy 15.5.2. Value ((US$ Billion) Analysis and Forecast by Market Taxonomy, 2017-2032 15.5.2.1. By Component 15.5.2.2. By Detection Technique 15.5.2.3. By End-user 15.6. Argentina Viral Antigens Market Analysis 15.6.1. Value Proportion Analysis by Market Taxonomy 15.6.2. Value ((US$ Billion) Analysis and Forecast by Market Taxonomy, 2017-2032 15.6.2.1. By Component 15.6.2.2. By Detection Technique 15.6.2.3. By End-user 15.7. Germany Viral Antigens Market Analysis 15.7.1. Value Proportion Analysis by Market Taxonomy 15.7.2. Value ((US$ Billion) Analysis and Forecast by Market Taxonomy, 2017-2032 15.7.2.1. By Component 15.7.2.2. By Detection Technique 15.7.2.3. By End-user 15.8. France Viral Antigens Market Analysis 15.8.1. Value Proportion Analysis by Market Taxonomy 15.8.2. Value ((US$ Billion) Analysis and Forecast by Market Taxonomy, 2017-2032 15.8.2.1. By Component 15.8.2.2. By Detection Technique 15.8.2.3. By End-user 15.9. Italy Viral Antigens Market Analysis 15.9.1. Value Proportion Analysis by Market Taxonomy 15.9.2. Value ((US$ Billion) Analysis and Forecast by Market Taxonomy, 2017-2032 15.9.2.1. By Component 15.9.2.2. By Detection Technique 15.9.2.3. By End-user 15.10. Spain Viral Antigens Market Analysis 15.10.1. Value Proportion Analysis by Market Taxonomy 15.10.2. Value ((US$ Billion) Analysis and Forecast by Market Taxonomy, 2017-2032 15.10.2.1. By Component 15.10.2.2. By Detection Technique 15.10.2.3. By End-user 15.11. BENELUX Viral Antigens Market Analysis 15.11.1. Value Proportion Analysis by Market Taxonomy 15.11.2. Value ((US$ Billion) Analysis and Forecast by Market Taxonomy, 2017-2032 15.11.2.1. By Component 15.11.2.2. By Detection Technique 15.11.2.3. By End-user 15.12. Russia Viral Antigens Market Analysis 15.12.1. Value Proportion Analysis by Market Taxonomy 15.12.2. Value ((US$ Billion) Analysis and Forecast by Market Taxonomy, 2017-2032 15.12.2.1. By Component 15.12.2.2. By Detection Technique 15.12.2.3. By End-user 15.13. U.K. Viral Antigens Market Analysis 15.13.1. Value Proportion Analysis by Market Taxonomy 15.13.2. Value ((US$ Billion) Analysis and Forecast by Market Taxonomy, 2017-2032 15.13.2.1. By Component 15.13.2.2. By Detection Technique 15.13.2.3. By End-user 15.14. China Viral Antigens Market Analysis 15.14.1. Value Proportion Analysis by Market Taxonomy 15.14.2. Value ((US$ Billion) Analysis and Forecast by Market Taxonomy, 2017-2032 15.14.2.1. By Component 15.14.2.2. By Detection Technique 15.14.2.3. By End-user 15.15. Japan Viral Antigens Market Analysis 15.15.1. Value Proportion Analysis by Market Taxonomy 15.15.2. Value ((US$ Billion) Analysis and Forecast by Market Taxonomy, 2017-2032 15.15.2.1. By Component 15.15.2.2. By Detection Technique 15.15.2.3. By End-user 15.16. South Korea Viral Antigens Market Analysis 15.16.1. Value Proportion Analysis by Market Taxonomy 15.16.2. Value ((US$ Billion) Analysis and Forecast by Market Taxonomy, 2017-2032 15.16.2.1. By Component 15.16.2.2. By Detection Technique 15.16.2.3. By End-user 15.17. India Viral Antigens Market Analysis 15.17.1. Value Proportion Analysis by Market Taxonomy 15.17.2. Value ((US$ Billion) Analysis and Forecast by Market Taxonomy, 2017-2032 15.17.2.1. By Component 15.17.2.2. By Detection Technique 15.17.2.3. By End-user 15.18. ASEAN Countries Viral Antigens Market Analysis 15.18.1. Value Proportion Analysis by Market Taxonomy 15.18.2. Value ((US$ Billion) Analysis and Forecast by Market Taxonomy, 2017-2032 15.18.2.1. By Component 15.18.2.2. By Detection Technique 15.18.2.3. By End-user 15.19. Australia Viral Antigens Market Analysis 15.19.1. Value Proportion Analysis by Market Taxonomy 15.19.2. Value ((US$ Billion) Analysis and Forecast by Market Taxonomy, 2017-2032 15.19.2.1. By Component 15.19.2.2. By Detection Technique 15.19.2.3. By End-user 15.20. GCC Countries Viral Antigens Market Analysis 15.20.1. Value Proportion Analysis by Market Taxonomy 15.20.2. Value ((US$ Billion) Analysis and Forecast by Market Taxonomy, 2017-2032 15.20.2.1. By Component 15.20.2.2. By Detection Technique 15.20.2.3. By End-user 15.21. Turkey Viral Antigens Market Analysis 15.21.1. Value Proportion Analysis by Market Taxonomy 15.21.2. Value ((US$ Billion) Analysis and Forecast by Market Taxonomy, 2017-2032 15.21.2.1. By Component 15.21.2.2. By Detection Technique 15.21.2.3. By End-user 15.22. South Africa Viral Antigens Market Analysis 15.22.1. Value Proportion Analysis by Market Taxonomy 15.22.2. Value ((US$ Billion) Analysis and Forecast by Market Taxonomy, 2017-2032 15.22.2.1. By Component 15.22.2.2. By Detection Technique 15.22.2.3. By End-user 16. Viral Antigens Market Structure Analysis 16.1. Market Analysis by Tier of Companies 16.2. Market Concentration of Players 16.3. Market Share Analysis of Top Players 16.4. Market Presence Analysis 17. Viral Antigens Competition Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking of Products 17.3. Competition Deep Dive: Viral Antigens 17.3.1. Microbix Biosystems Inc. 17.3.1.1. Overview 17.3.1.2. Product Portfolio 17.3.1.3. Key Financials 17.3.1.4. Sales Footprint 17.3.1.5. SWOT Analysis 17.3.1.6. Key Developments 17.3.1.7. Strategy Overview 17.3.2. Bio Rad Laboratories 17.3.2.1. Overview 17.3.2.2. Product Portfolio 17.3.2.3. Key Financials 17.3.2.4. Sales Footprint 17.3.2.5. SWOT Analysis 17.3.2.6. Key Developments 17.3.2.7. Strategy Overview 17.3.3. Creative Diagnostics 17.3.3.1. Overview 17.3.3.2. Product Portfolio 17.3.3.3. Key Financials 17.3.3.4. Sales Footprint 17.3.3.5. SWOT Analysis 17.3.3.6. Key Developments 17.3.3.7. Strategy Overview 17.3.4. Aalto Bio Reagents 17.3.4.1. Overview 17.3.4.2. Product Portfolio 17.3.4.3. Key Financials 17.3.4.4. Sales Footprint 17.3.4.5. SWOT Analysis 17.3.4.6. Key Developments 17.3.4.7. Strategy Overview 17.3.5. ProSpec-Tany TechnoGene Ltd. 17.3.5.1. Overview 17.3.5.2. Product Portfolio 17.3.5.3. Key Financials 17.3.5.4. Sales Footprint 17.3.5.5. SWOT Analysis 17.3.5.6. Key Developments 17.3.5.7. Strategy Overview 17.3.6. The native antigen company 17.3.6.1. Overview 17.3.6.2. Product Portfolio 17.3.6.3. Key Financials 17.3.6.4. Sales Footprint 17.3.6.5. SWOT Analysis 17.3.6.6. Key Developments 17.3.6.7. Strategy Overview 17.3.7. Meridian bioscience 17.3.7.1. Overview 17.3.7.2. Product Portfolio 17.3.7.3. Key Financials 17.3.7.4. Sales Footprint 17.3.7.5. SWOT Analysis 17.3.7.6. Key Developments 17.3.7.7. Strategy Overview 17.3.8. Inbios 17.3.8.1. Overview 17.3.8.2. Product Portfolio 17.3.8.3. Key Financials 17.3.8.4. Sales Footprint 17.3.8.5. SWOT Analysis 17.3.8.6. Key Developments 17.3.8.7. Strategy Overview 17.3.9. Rekom biotech 17.3.9.1. Overview 17.3.9.2. Product Portfolio 17.3.9.3. Key Financials 17.3.9.4. Sales Footprint 17.3.9.5. SWOT Analysis 17.3.9.6. Key Developments 17.3.9.7. Strategy Overview 17.3.10. Sekbio 17.3.10.1. Overview 17.3.10.2. Product Portfolio 17.3.10.3. Key Financials 17.3.10.4. Sales Footprint 17.3.10.5. SWOT Analysis 17.3.10.6. Key Developments 17.3.10.7. Strategy Overview 17.3.11. Others (On Additional Request) 17.3.11.1. Overview 17.3.11.2. Product Portfolio 17.3.11.3. Key Financials 17.3.11.4. Sales Footprint 17.3.11.5. SWOT Analysis 17.3.11.6. Key Developments 17.3.11.7. Strategy Overview 18. Assumptions & Acronyms Used 19. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Viral Antigens Value ((US$ Billion) and Forecast by Region, 2017-2021
Table 02: Global Viral Antigens Value (US$ Billion) and Forecast by Region, 2022-2032
Table 03: Global Viral Antigens Value (US$ Billion) and Forecast by Components, 2017-2021
Table 04: Global Viral Antigens Value (US$ Billion) and Forecast by Components, 2022-2032
Table 05: Global Viral Antigens Value (US$ Billion) and Forecast By Detection Technique, 2017-2021
Table 06: Global Viral Antigens Value (US$ Billion) and Forecast By Detection Technique, 2022-2032
Table 07: Global Viral Antigens Value (US$ Billion) and Forecast by End-user, 2017-2021
Table 08: Global Viral Antigens Value (US$ Billion) and Forecast by End-user, 2022-2032
Table 09: North America Viral Antigens Value (US$ Billion) and Forecast by Country, 2017-2021
Table 10: North America Viral Antigens Value (US$ Billion) and Forecast by Country, 2022-2032
Table 11: North America Viral Antigens Value (US$ Billion) and Forecast by Components, 2017-2021
Table 12: North America Viral Antigens Value (US$ Billion) and Forecast by Components, 2022-2032
Table 13: North America Viral Antigens Value (US$ Billion) and Forecast By Detection Technique, 2017-2021
Table 14: North America Viral Antigens Value (US$ Billion) and Forecast By Detection Technique, 2022-2032
Table 15: North America Viral Antigens Value (US$ Billion) and Forecast by End-user, 2017-2021
Table 16: North America Viral Antigens Value (US$ Billion) and Forecast by End-user, 2022-2032
Table 17: Latin America Viral Antigens Value (US$ Billion) and Forecast by Country, 2017-2021
Table 18: Latin America Viral Antigens Value (US$ Billion) and Forecast by Country, 2022-2032
Table 19: Latin America Viral Antigens Value (US$ Billion) and Forecast by Components, 2017-2021
Table 20: Latin America Viral Antigens Value (US$ Billion) and Forecast by Components, 2022-2032
Table 21: Latin America Viral Antigens Value (US$ Billion) and Forecast By Detection Technique, 2017-2021
Table 22: Latin America Viral Antigens Value (US$ Billion) and Forecast By Detection Technique, 2022-2032
Table 23: Latin America Viral Antigens Value (US$ Billion) and Forecast by End-user, 2017-2021
Table 24: Latin America Viral Antigens Value (US$ Billion) and Forecast by End-user, 2022-2032
Table 25: Europe Viral Antigens Value (US$ Billion) and Forecast by Country, 2017-2021
Table 26: Europe Viral Antigens Value (US$ Billion) and Forecast by Country, 2022-2032
Table 27: Europe Viral Antigens Value (US$ Billion) and Forecast by Components, 2017-2021
Table 28: Europe Viral Antigens Value (US$ Billion) and Forecast by Components, 2022-2032
Table 29: Europe Viral Antigens Value (US$ Billion) and Forecast By Detection Technique, 2017-2021
Table 30: Europe Viral Antigens Value (US$ Billion) and Forecast By Detection Technique, 2022-2032
Table 31: Europe Viral Antigens Value (US$ Billion) and Forecast by End-user, 2017-2021
Table 32: Europe Viral Antigens Value (US$ Billion) and Forecast by End-user, 2022-2032
Table 33: East Asia Viral Antigens Value (US$ Billion) and Forecast by Country, 2017-2021
Table 34: East Asia Viral Antigens Value (US$ Billion) and Forecast by Country, 2022-2032
Table 35: East Asia Viral Antigens Value (US$ Billion) and Forecast by Components, 2017-2021
Table 36: East Asia Viral Antigens Value (US$ Billion) and Forecast by Components, 2022-2032
Table 37: East Asia Viral Antigens Value (US$ Billion) and Forecast By Detection Technique, 2017-2021
Table 38: East Asia Viral Antigens Value (US$ Billion) and Forecast By Detection Technique, 2022-2032
Table 39: East Asia Viral Antigens Value (US$ Billion) and Forecast by End-user, 2017-2021
Table 40: East Asia Viral Antigens Value (US$ Billion) and Forecast by End-user, 2022-2032
Table 41: South Asia and ASEAN Viral Antigens Value (US$ Billion) and Forecast by Country, 2017-2021
Table 42: South Asia and ASEAN Viral Antigens Value (US$ Billion) and Forecast by Country, 2022-2032
Table 43: South Asia and ASEAN Viral Antigens Value (US$ Billion) and Forecast by Components, 2017-2021
Table 44: South Asia and ASEAN Viral Antigens Value (US$ Billion) and Forecast by Components, 2022-2032
Table 45: South Asia and ASEAN Viral Antigens Value (US$ Billion) and Forecast By Detection Technique, 2017-2021
Table 46: South Asia and ASEAN Viral Antigens Value (US$ Billion) and Forecast By Detection Technique, 2022-2032
Table 47: South Asia and ASEAN Viral Antigens Value (US$ Billion) and Forecast by End-user, 2017-2021
Table 48: South Asia and ASEAN Viral Antigens Value (US$ Billion) and Forecast by End-user, 2022-2032
Table 49: Oceania Viral Antigens Value (US$ Billion) and Forecast by Country, 2017-2021
Table 50: Oceania Viral Antigens Value (US$ Billion) and Forecast by Country, 2022-2032
Table 51: Oceania Viral Antigens Value (US$ Billion) and Forecast by Components, 2017-2021
Table 52: Oceania Viral Antigens Value (US$ Billion) and Forecast by Components, 2022-2032
Table 53: Oceania Viral Antigens Value (US$ Billion) and Forecast By Detection Technique, 2017-2021
Table 54: Oceania Viral Antigens Value (US$ Billion) and Forecast By Detection Technique, 2022-2032
Table 55: Oceania Viral Antigens Value (US$ Billion) and Forecast by End-user, 2017-2021
Table 56: Oceania Viral Antigens Value (US$ Billion) and Forecast by End-user, 2022-2032
Table 57: MEA Viral Antigens Value (US$ Billion) and Forecast by Country, 2017-2021
Table 58: MEA Viral Antigens Value (US$ Billion) and Forecast by Country, 2022-2032
Table 59: MEA Viral Antigens Value (US$ Billion) and Forecast by Components, 2017-2021
Table 60: MEA Viral Antigens Value (US$ Billion) and Forecast by Components, 2022-2032
Table 61: MEA Viral Antigens Value (US$ Billion) and Forecast By Detection Technique, 2017-2021
Table 62: MEA Viral Antigens Value (US$ Billion) and Forecast By Detection Technique, 2022-2032
Table 63: MEA Viral Antigens Value (US$ Billion) and Forecast by End-user, 2017-2021
Table 64: MEA Viral Antigens Value (US$ Billion) and Forecast by End-user, 2022-2032
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Viral Antigens Market Value ((US$ Billion) Forecast, 2022-2032
Figure 02: Global Viral Antigens Market Absolute $ Opportunity ((US$ Billion), 2022-2032
Figure 03: Global Viral Antigens Market Value ((US$ Billion) by Region, 2022 & 2032
Figure 04: Global Viral Antigens Market Y-o-Y Growth Rate by Region, 2022-2032
Figure 05: Global Viral Antigens Market Value ((US$ Billion) by Component, 2022 & 2032
Figure 06: Global Viral Antigens Market Y-o-Y Growth Rate by Component, 2022-2032
Figure 07: Global Viral Antigens Market Value ((US$ Billion) By Detection Technique, 2022 & 2032
Figure 08: Global Viral Antigens Market Y-o-Y Growth Rate By Detection Technique, 2022-2032
Figure 09: Global Viral Antigens Market Value ((US$ Billion) by End-user, 2022 & 2032
Figure 10: Global Viral Antigens Market Y-o-Y Growth Rate by End-user, 2022-2032
Figure 11: North America Viral Antigens Market Value ((US$ Billion) Forecast, 2022-2032
Figure 12: North America Viral Antigens Market Absolute $ Opportunity ((US$ Billion), 2022-2032
Figure 13: North America Viral Antigens Market Value ((US$ Billion) by Country, 2022 & 2032
Figure 14: North America Viral Antigens Market Y-o-Y Growth Rate by Country, 2022-2032
Figure 15: North America Viral Antigens Market Value ((US$ Billion) by Component, 2022 & 2032
Figure 16: North America Viral Antigens Market Y-o-Y Growth Rate by Component, 2022-2032
Figure 17: North America Viral Antigens Market Value ((US$ Billion) By Detection Technique, 2022 & 2032
Figure 18: North America Viral Antigens Market Y-o-Y Growth Rate By Detection Technique, 2022-2032
Figure 19: North America Viral Antigens Market Value ((US$ Billion) by End-user, 2022 & 2032
Figure 20: North America Viral Antigens Market Y-o-Y Growth Rate by End-user, 2022-2032
Figure 21: North America Viral Antigens Market Attractiveness Analysis by Country, 2022-2032
Figure 22: North America Viral Antigens Market Attractiveness Analysis by Component, 2022-2032
Figure 23: North America Viral Antigens Market Attractiveness Analysis By Detection Technique, 2022-2032
Figure 24: North America Viral Antigens Market Attractiveness Analysis by End-user, 2022-2032
Figure 25: Latin America Viral Antigens Market Value ((US$ Billion) Forecast, 2022-2032
Figure 26: Latin America Viral Antigens Market Absolute $ Opportunity ((US$ Billion), 2022-2032
Figure 27: Latin America Viral Antigens Market Value ((US$ Billion) by Country, 2022 & 2032
Figure 28: Latin America Viral Antigens Market Y-o-Y Growth Rate by Country, 2022-2032
Figure 29: Latin America Viral Antigens Market Value ((US$ Billion) by Component, 2022 & 2032
Figure 30: Latin America Viral Antigens Market Y-o-Y Growth Rate by Component, 2022-2032
Figure 31: Latin America Viral Antigens Market Value ((US$ Billion) By Detection Technique, 2022 & 2032
Figure 32: Latin America Viral Antigens Market Y-o-Y Growth Rate By Detection Technique, 2022-2032
Figure 33: Latin America Viral Antigens Market Value ((US$ Billion) by End-user, 2022 & 2032
Figure 34: Latin America Viral Antigens Market Y-o-Y Growth Rate by End-user, 2022-2032
Figure 35: Latin America Viral Antigens Market Attractiveness Analysis by Country, 2022-2032
Figure 36: Latin America Viral Antigens Market Attractiveness Analysis by Component, 2022-2032
Figure 37: Latin America Viral Antigens Market Attractiveness Analysis By Detection Technique, 2022-2032
Figure 38: Latin America Viral Antigens Market Attractiveness Analysis by End-user, 2022-2032
Figure 39: Europe Viral Antigens Market Value ((US$ Billion) Forecast, 2022-2032
Figure 40: Europe Viral Antigens Market Absolute $ Opportunity ((US$ Billion), 2022-2032
Figure 41: Europe Viral Antigens Market Value ((US$ Billion) by Country, 2022 & 2032
Figure 42: Europe Viral Antigens Market Y-o-Y Growth Rate by Country, 2022-2032
Figure 43: Europe Viral Antigens Market Value ((US$ Billion) by Component, 2022 & 2032
Figure 44: Europe Viral Antigens Market Y-o-Y Growth Rate by Component, 2022-2032
Figure 45: Europe Viral Antigens Market Value ((US$ Billion) By Detection Technique, 2022 & 2032
Figure 46: Europe Viral Antigens Market Y-o-Y Growth Rate By Detection Technique, 2022-2032
Figure 47: Europe Viral Antigens Market Value ((US$ Billion) by End-user, 2022 & 2032
Figure 48: Europe Viral Antigens Market Y-o-Y Growth Rate by End-user, 2022-2032
Figure 49: Europe Viral Antigens Market Attractiveness Analysis by Country, 2022-2032
Figure 50: Europe Viral Antigens Market Attractiveness Analysis by Component, 2022-2032
Figure 51: Europe Viral Antigens Market Attractiveness Analysis By Detection Technique, 2022-2032
Figure 52: Europe Viral Antigens Market Attractiveness Analysis by End-user, 2022-2032
Figure 53: East Asia Viral Antigens Market Value ((US$ Billion) Forecast, 2022-2032
Figure 54: East Asia Viral Antigens Market Absolute $ Opportunity ((US$ Billion), 2022-2032
Figure 55: East Asia Viral Antigens Market Value ((US$ Billion) by Country, 2022 & 2032
Figure 56: East Asia Viral Antigens Market Y-o-Y Growth Rate by Country, 2022-2032
Figure 57: East Asia Viral Antigens Market Value ((US$ Billion) by Component, 2022 & 2032
Figure 58: East Asia Viral Antigens Market Y-o-Y Growth Rate by Component, 2022-2032
Figure 59: East Asia Viral Antigens Market Value ((US$ Billion) By Detection Technique, 2022 & 2032
Figure 60: East Asia Viral Antigens Market Y-o-Y Growth Rate By Detection Technique, 2022-2032
Figure 61: East Asia Viral Antigens Market Value ((US$ Billion) by End-user, 2022 & 2032
Figure 62: East Asia Viral Antigens Market Y-o-Y Growth Rate by End-user, 2022-2032
Figure 63: East Asia Viral Antigens Market Attractiveness Analysis by Country, 2022-2032
Figure 64: East Asia Viral Antigens Market Attractiveness Analysis by Component, 2022-2032
Figure 65: East Asia Viral Antigens Market Attractiveness Analysis By Detection Technique, 2022-2032
Figure 66: East Asia Viral Antigens Market Attractiveness Analysis by End-user, 2022-2032
Figure 67: South Asia and ASEAN Viral Antigens Market Value ((US$ Billion) Forecast, 2022-2032
Figure 68: South Asia and ASEAN Viral Antigens Market Absolute $ Opportunity ((US$ Billion), 2022-2032
Figure 69: South Asia and ASEAN Viral Antigens Market Value ((US$ Billion) by Country, 2022 & 2032
Figure 70: South Asia and ASEAN Viral Antigens Market Y-o-Y Growth Rate by Country, 2022-2032
Figure 71: South Asia and ASEAN Viral Antigens Market Value ((US$ Billion) by Component, 2022 & 2032
Figure 72: South Asia and ASEAN Viral Antigens Market Y-o-Y Growth Rate by Component, 2022-2032
Figure 73: South Asia and ASEAN Viral Antigens Market Value ((US$ Billion) By Detection Technique, 2022 & 2032
Figure 74: South Asia and ASEAN Viral Antigens Market Y-o-Y Growth Rate By Detection Technique, 2022-2032
Figure 75: South Asia and ASEAN Viral Antigens Market Value ((US$ Billion) by End-user, 2022 & 2032
Figure 76: South Asia and ASEAN Viral Antigens Market Y-o-Y Growth Rate by End-user, 2022-2032
Figure 77: South Asia and ASEAN Viral Antigens Market Attractiveness Analysis by Country, 2022-2032
Figure 78: South Asia and ASEAN Viral Antigens Market Attractiveness Analysis by Component, 2022-2032
Figure 79: South Asia and ASEAN Viral Antigens Market Attractiveness Analysis By Detection Technique, 2022-2032
Figure 80: South Asia and ASEAN Viral Antigens Market Attractiveness Analysis by End-user, 2022-2032
Figure 81: Oceania Viral Antigens Market Value ((US$ Billion) Forecast, 2022-2032
Figure 82: Oceania Viral Antigens Market Absolute $ Opportunity ((US$ Billion), 2022-2032
Figure 83: Oceania Viral Antigens Market Value ((US$ Billion) by Country, 2022 & 2032
Figure 84: Oceania Viral Antigens Market Y-o-Y Growth Rate by Country, 2022-2032
Figure 85: Oceania Viral Antigens Market Value ((US$ Billion) by Component, 2022 & 2032
Figure 86: Oceania Viral Antigens Market Y-o-Y Growth Rate by Component, 2022-2032
Figure 87: Oceania Viral Antigens Market Value ((US$ Billion) By Detection Technique, 2022 & 2032
Figure 88: Oceania Viral Antigens Market Y-o-Y Growth Rate By Detection Technique, 2022-2032
Figure 89: Oceania Viral Antigens Market Value ((US$ Billion) by End-user, 2022 & 2032
Figure 90: Oceania Viral Antigens Market Y-o-Y Growth Rate by End-user, 2022-2032
Figure 91: Oceania Viral Antigens Market Attractiveness Analysis by Country, 2022-2032
Figure 92: Oceania Viral Antigens Market Attractiveness Analysis by Component, 2022-2032
Figure 93: Oceania Viral Antigens Market Attractiveness Analysis By Detection Technique, 2022-2032
Figure 94: Oceania Viral Antigens Market Attractiveness Analysis by End-user, 2022-2032
Figure 95: MEA Viral Antigens Market Value ((US$ Billion) Forecast, 2022-2032
Figure 96: MEA Viral Antigens Market Absolute $ Opportunity ((US$ Billion), 2022-2032
Figure 97: MEA Viral Antigens Market Value ((US$ Billion) by Country, 2022 & 2032
Figure 98: MEA Viral Antigens Market Y-o-Y Growth Rate by Country, 2022-2032
Figure 99: MEA Viral Antigens Market Value ((US$ Billion) by Component, 2022 & 2032
Figure 100: MEA Viral Antigens Market Y-o-Y Growth Rate by Component, 2022-2032
Figure 101: MEA Viral Antigens Market Value ((US$ Billion) By Detection Technique, 2022 & 2032
Figure 102: MEA Viral Antigens Market Y-o-Y Growth Rate By Detection Technique, 2022-2032
Figure 103: MEA Viral Antigens Market Value ((US$ Billion) by End-user, 2022 & 2032
Figure 104: MEA Viral Antigens Market Y-o-Y Growth Rate by End-user, 2022-2032
Figure 105: MEA Viral Antigens Market Attractiveness Analysis by Country, 2022-2032
Figure 106: MEA Viral Antigens Market Attractiveness Analysis by Component, 2022-2032
Figure 107: MEA Viral Antigens Market Attractiveness Analysis By Detection Technique, 2022-2032
Figure 108: MEA Viral Antigens Market Attractiveness Analysis by End-user, 2022-2032
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How is the market predicted to evolve going forward?
Revenue from the sales of viral antigens is anticipated to reach US$ 388.1 billion by 2032-end.
Which detection technique is most popular in this landscape?
The ELISA detection technique accounts for 31.6% share of the global market.
What is the global viral antigens market value?
The global viral antigens market is estimated at US$ 175.9 billion in 2022.
Which regional market is being targeted by most industry participants?
North America tops the global viral antigens market and accounts for 49.3% market share in 2022.
How did the viral antigens market fare over the historical period?
From 2017 to 2021, worldwide sales of viral antigens increased at 7.7% CAGR.
Viral Antigens Market